CCR2 and medulloblastoma: A Kaplan–Meier survival curve illustrated a significant decrease in median survival for Ccr2RFP/RFP (53 days) mice bearing medulloblastoma compared to Ccr2+/+ mice (83 days; Fig. 4b).